GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 678 filers reported holding GLAXOSMITHKLINE PLC in Q4 2013. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,389,000 | -56.9% | 115,860 | -51.4% | 0.48% | -11.9% |
| Q3 2019 | $10,178,000 | +137.7% | 238,479 | +122.9% | 0.54% | +227.7% |
| Q2 2019 | $4,281,000 | +6.1% | 106,978 | +10.7% | 0.17% | -28.8% |
| Q1 2019 | $4,036,000 | +25.3% | 96,600 | +29.3% | 0.23% | +385.4% |
| Q2 2017 | $3,221,000 | -42.7% | 74,700 | -42.7% | 0.05% | -74.2% |
| Q3 2016 | $5,624,000 | +84.0% | 130,400 | +72.9% | 0.19% | +25.7% |
| Q1 2016 | $3,057,000 | +341.8% | 75,400 | +402.7% | 0.15% | +124.2% |
| Q1 2015 | $692,000 | +5.3% | 15,000 | +4.9% | 0.07% | -48.0% |
| Q3 2014 | $657,000 | +21.9% | 14,300 | +41.6% | 0.13% | +388.5% |
| Q1 2014 | $539,000 | +98.2% | 10,100 | +98.0% | 0.03% | 0.0% |
| Q4 2013 | $272,000 | -85.9% | 5,100 | -86.8% | 0.03% | -92.4% |
| Q2 2013 | $1,928,000 | – | 38,600 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
| Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
| KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
| Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
| EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
| Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
| Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
| Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
| Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
| CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |